Invited Editorial
Recognizing the temporal variability of adverse events after HeartMate 3 implantation: Tackling the expected event at the right time
-
Time-varying analyses of survival and outcomes in patients with HeartMate 3 left ventricular assist devices
- Aaron J. Weiss,
- Jean-Luc A. Maigrot,
- Michael Z.Y. Tong,
- Lucy Thuita,
- Nicholas G. Smedira,
- Shinya Unai,
- Pavan Bhat,
- Maria Mountis,
- Eugene H. Blackstone,
- Randall C. Starling,
- Edward G. Soltesz,
- Volume 27Issue 5European Journal of Heart Failure
- pages: 822-829
- First Published online: January 9, 2025
Yoav Hammer,
Yoav Hammer
Heart Failure Unit, Rabin Medical Center, Petah Tikva, Israel
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for more papers by this author Tuvia Ben Gal,
Corresponding Author
Tuvia Ben Gal
Heart Failure Unit, Rabin Medical Center, Petah Tikva, Israel
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Corresponding author. Heart Failure Unit, Rabin Medical Center, Petah Tikva, Israel. Tel: +972 52 2757616, Fax: +972 3 9377337, Email: [email protected]
Search for more papers by this author
Yoav Hammer,
Yoav Hammer
Heart Failure Unit, Rabin Medical Center, Petah Tikva, Israel
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for more papers by this author Tuvia Ben Gal,
Corresponding Author
Tuvia Ben Gal
Heart Failure Unit, Rabin Medical Center, Petah Tikva, Israel
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Corresponding author. Heart Failure Unit, Rabin Medical Center, Petah Tikva, Israel. Tel: +972 52 2757616, Fax: +972 3 9377337, Email: [email protected]
Search for more papers by this author
First published: 05 February 2025
No abstract is available for this article.
References
- 1Meyer DM, Nayak A, Wood KL, Blumer V, Schettle S, Salerno C, et al. The Society of Thoracic Surgeons Intermacs 2024 annual report: Focus on outcomes in younger patients. Ann Thorac Surg 2025; 119: 34–58. https://doi.org/10.1016/j.athoracsur.2024.10.003
- 2Mehra MR, Uriel N, Naka Y, Cleveland JC Jr, Yuzefpolskaya M, Salerno CT, et al.; MOMENTUM 3 Investigators. A fully magnetically levitated left ventricular assist device – final report. N Engl J Med 2019; 380: 1618–1627. https://doi.org/10.1056/NEJMoa1900486
- 3Hammer Y, Xie J, Yang G, Bitar A, Haft JW, Cascino TM, et al. Gastrointestinal bleeding following HeartMate 3 left ventricular assist device implantation: The Michigan Bleeding Risk Model. J Heart Lung Transplant 2024; 43: 604–614. https://doi.org/10.1016/j.healun.2023.11.016
- 4Weiss AJ, Maigrot JA, Tong MZY, Thuita L, Smedira NG, Unai S, et al. Time-varying analyses of survival and outcomes in patients with HeartMate 3 left ventricular assist devices. Eur J Heart Fail 2025; 27: 822–829. https://doi.org/10.1002/ejhf.3577
- 5Mehra MR, Netuka I, Uriel N, Katz JN, Pagani FD, Jorde UP, et al.; ARIES-HM3 Investigators. Aspirin and hemocompatibility events with a left ventricular assist device in advanced heart failure: The ARIES-HM3 randomized clinical trial. JAMA 2023; 330: 2171–2181. https://doi.org/10.1001/jama.2023.23204
- 6Rizvi SA, Luc JGY, Choi JH, Phan K, Moncho Escrivà E, Patel S, et al. Outcomes and survival following heart retransplantation for cardiac allograft failure: A systematic review and meta-analysis. Ann Cardiothorac Surg 2018; 7: 12–18. https://doi.org/10.21037/acs.2018.01.09
